Speaker illustration

Mrs Ulrike Theidel

Xcenda GmbH, Hannover (Germany)

Budget impact of iv iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany

Event: HEART FAILURE 2016

Topic: Chronic nursing care

Session: Clinical Forum - Sat. 21 May 08:30 - Sun. 22 May 18:00

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb